| Tamara Gutierrez, Llc | |
|
3870 E Flamingo Rd Ste A3, Las Vegas, NV 89121-6241 | |
| (702) 434-9919 | |
| (702) 270-0926 |
| Full Name | Tamara Gutierrez, Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 3870 E Flamingo Rd Ste A3, Las Vegas, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003016072 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 484 (Nevada) | Primary |
| Provider Name | Tamara L Gutierrez |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1396809927 PECOS PAC ID: 7618983941 Enrollment ID: I20060223000790 |
News Archive
A team of researchers are investigating why despite low forecasts of pollen counts, on some days, there is a higher incidence of hay fever.
The National Community Pharmacists Association (NCPA) thanks Congress for including key pharmacy provisions in the Defense Authorization Act Conference Report for fiscal year 2008 it passed last week.
Three antibiotics that, individually, are not effective against a drug-resistant staph infection can kill the deadly pathogen when combined as a trio, according to new research.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq) and IG-004 (TOCOSOL paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine and the European Technology Platform on Nanomedicine in Basel, Switzerland on June 23 - 26.
Results of the NRG Oncology clinical trial NRG-HN002 indicated that the combination of intensity-modulated radiotherapy (IMRT) and cisplatin was able to meet acceptability criteria for progression-free survival (PFS) and swallowing-related quality of life for patients who have p16-positive, non-smoking-associated oropharyngeal cancer.
› Verified 4 days ago
| Provider Name | Marilyn Gonzalez |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1235166109 PECOS PAC ID: 0446260632 Enrollment ID: I20060505000154 |
News Archive
A team of researchers are investigating why despite low forecasts of pollen counts, on some days, there is a higher incidence of hay fever.
The National Community Pharmacists Association (NCPA) thanks Congress for including key pharmacy provisions in the Defense Authorization Act Conference Report for fiscal year 2008 it passed last week.
Three antibiotics that, individually, are not effective against a drug-resistant staph infection can kill the deadly pathogen when combined as a trio, according to new research.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq) and IG-004 (TOCOSOL paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine and the European Technology Platform on Nanomedicine in Basel, Switzerland on June 23 - 26.
Results of the NRG Oncology clinical trial NRG-HN002 indicated that the combination of intensity-modulated radiotherapy (IMRT) and cisplatin was able to meet acceptability criteria for progression-free survival (PFS) and swallowing-related quality of life for patients who have p16-positive, non-smoking-associated oropharyngeal cancer.
› Verified 4 days ago
| Provider Name | Beena M Patel |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1073156824 PECOS PAC ID: 3971937541 Enrollment ID: I20200107003351 |
News Archive
A team of researchers are investigating why despite low forecasts of pollen counts, on some days, there is a higher incidence of hay fever.
The National Community Pharmacists Association (NCPA) thanks Congress for including key pharmacy provisions in the Defense Authorization Act Conference Report for fiscal year 2008 it passed last week.
Three antibiotics that, individually, are not effective against a drug-resistant staph infection can kill the deadly pathogen when combined as a trio, according to new research.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq) and IG-004 (TOCOSOL paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine and the European Technology Platform on Nanomedicine in Basel, Switzerland on June 23 - 26.
Results of the NRG Oncology clinical trial NRG-HN002 indicated that the combination of intensity-modulated radiotherapy (IMRT) and cisplatin was able to meet acceptability criteria for progression-free survival (PFS) and swallowing-related quality of life for patients who have p16-positive, non-smoking-associated oropharyngeal cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tamara Gutierrez, Llc 2429 Amoretti St, Henderson, NV 89052-5757 Ph: (702) 769-5755 | Tamara Gutierrez, Llc 3870 E Flamingo Rd Ste A3, Las Vegas, NV 89121-6241 Ph: (702) 434-9919 |
News Archive
A team of researchers are investigating why despite low forecasts of pollen counts, on some days, there is a higher incidence of hay fever.
The National Community Pharmacists Association (NCPA) thanks Congress for including key pharmacy provisions in the Defense Authorization Act Conference Report for fiscal year 2008 it passed last week.
Three antibiotics that, individually, are not effective against a drug-resistant staph infection can kill the deadly pathogen when combined as a trio, according to new research.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq) and IG-004 (TOCOSOL paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine and the European Technology Platform on Nanomedicine in Basel, Switzerland on June 23 - 26.
Results of the NRG Oncology clinical trial NRG-HN002 indicated that the combination of intensity-modulated radiotherapy (IMRT) and cisplatin was able to meet acceptability criteria for progression-free survival (PFS) and swallowing-related quality of life for patients who have p16-positive, non-smoking-associated oropharyngeal cancer.
› Verified 4 days ago
Dr. Joseph Peter Wadoski, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3350 E Tropicana Ave, Las Vegas, NV 89121 Phone: 702-839-0200 Fax: 702-804-0201 | |
Dr. Keri Asraf, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8230 W Sahara Ave Ste 121, Las Vegas, NV 89117 Phone: 702-944-2001 | |
Mayer Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 1320 E Pebble Rd, Suite 100, Las Vegas, NV 89123 Phone: 702-818-3100 Fax: 702-485-6085 | |
Dr. Edward Joseph Malik, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 11035 Lavender Hill Dr Ste 180, Las Vegas, NV 89135 Phone: 702-254-0332 Fax: 702-685-4112 | |
Daniel Truong, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 6230 N Durango Dr, Las Vegas, NV 89149 Phone: 702-737-3937 Fax: 702-737-8860 | |
Dr. Elizabeth Dong-hee Suh, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5060 S Fort Apache Rd Ste 150, Las Vegas, NV 89148 Phone: 702-586-5222 Fax: 702-586-5224 |